WallStSmart

Medtronic PLC (MDT)vsTandem Diabetes Care Inc (TNDM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 3397% more annual revenue ($35.48B vs $1.01B). MDT leads profitability with a 13.0% profit margin vs -20.2%. MDT earns a higher WallStSmart Score of 56/100 (C).

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0

TNDM

Avoid

27

out of 100

Grade: F

Growth: 4.0Profit: 2.5Value: 5.0Quality: 4.0
Piotroski: 3/9Altman Z: -0.92
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTSignificantly Overvalued (-260.2%)

Margin of Safety

-260.2%

Fair Value

$24.34

Current Price

$87.89

$63.55 premium

UndervaluedFair: $24.34Overvalued

Intrinsic value data unavailable for TNDM.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$112.84B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

TNDM0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

TNDM4 concerns · Avg: 3.5/10
Price/BookValuation
10.7x4/10

Trading at 10.7x book value

Revenue GrowthGrowth
2.7%4/10

2.7% revenue growth

Market CapQuality
$1.66B3/10

Smaller company, higher risk/reward

Operating MarginProfitability
2.9%3/10

Operating margin of 2.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bull Case : TNDM

TNDM has a balanced fundamental profile.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : TNDM

The primary concerns for TNDM are Price/Book, Revenue Growth, Market Cap. Debt-to-equity of 3.64 is elevated, increasing financial risk.

Key Dynamics to Monitor

MDT profiles as a value stock while TNDM is a turnaround play — different risk/reward profiles.

TNDM carries more volatility with a beta of 1.67 — expect wider price swings.

MDT is growing revenue faster at 8.7% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (56/100 vs 27/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Tandem Diabetes Care Inc

HEALTHCARE · MEDICAL DEVICES · USA

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United States. The company is headquartered in San Diego, California.

Visit Website →

Want to dig deeper into these stocks?